United Kingdom· GB-APID-3635911000001103
Celance 1mg tablets
A pergolide product containing pergolide, registered in United Kingdom by Eli Lilly and Company Ltd. The same ATC class is registered in 3 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Pergolide is registered in 3 of 19 countries.
Countries holding a registration under ATC N04BC02 (pergolide), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 1 of them publish a price we can compare per daily dose
Pergolide · ATC N04BC02
3 / 19 countries
- Finlandprice
- Japan
- United Kingdom
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Pergolide
- Manufacturer
- Eli Lilly and Company Ltd
- Country
- United Kingdom (GB)
- ATC code
- N04BC02
- ATC class
- Pergolide
- Defined daily dose
- 3 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5014602400552
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
81 interactions on record for pergolide.
Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Pergolide · interactions on record
81 records
- 1 severe
- 55 moderate
- 25 info
Most severe, free to view
- LorcaserinA08AA11severe
- MetoclopramideA03FA01moderate
- ThiethylperazinA04AB03moderate
- DiphenhydraminA04AB05moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Pergolide in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e776e6a6-dbdd-4fc4-abf8-375023c89227 GET /v1/drugs/e776e6a6-dbdd-4fc4-abf8-375023c89227?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "3635911000001103",
"desc": "Celance 1mg tablets (Eli Lilly and Company Ltd)",
"form": "Oral tablet",
"vpid": "39702211000001104",
"source": "dmd",
"vtm_id": "777139007",
"strength": "1 mg",
"substance": "Pergolide",
"ingredient": "Pergolide mesilate",
"supplier_code": "2075101000001100"
}See everything about pergolide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.